Skip to content

Evaluation of Pilgrims Hospices rapid response community end of life service in East Kent

Evaluation of Pilgrims Hospices rapid response community end of life service in East Kent: A Quasi-experimental multi-centre controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32119670
Enrollment
1005
Registered
2012-06-22
Start date
2010-01-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: National Cancer Research Network, Generic Health Relevance and Cross Cutting Themes

Interventions

Hospice at home, The main features of the intervention are that it: 1. Is available to patients in their own home 2. Has a robust ?hospice standard? assessment 3. Provides hands on care 4. Responds r

Sponsors

East Kent Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients referred to the Pilgrims Hospices during the study and who die during the data collection period will be entered into the study. 2. All carers and bereaved carers who are able to consent will be eligible to participate. 3. Target Gender: Male & Female ; Lower Age Limit 18 years

Exclusion criteria

Exclusion criteria: Carers and bereaved carers not capable of giving consent

Design outcomes

Primary

MeasureTime frame
Patient preferred place of death

Secondary

MeasureTime frame
1. Carer quality of life and well-being - Carer outcomes will be measured at baseline on patient intake and 8 months later using self completion postal questionnaires. The outcome measures included in the questionnaire are the short-form SF12, measure of anxiety and depression (HADS), a measure of health utility (EQ-5D), and caregiving demand measured at baseline only. 2. Cost evaluation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026